TY - JOUR
T1 - New Gram-positive agents in nosocomial infection
AU - Patterson, Jan E.
PY - 2000
Y1 - 2000
N2 - Multidrug-resistant Gram-positive pathogens such as vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and methicillin-resistant coagulase-negative staphylococci account for a significant number of nosocomial infections, and new options for therapy have been lacking. During the past year, two agents have been released that have activity against these organisms: quinupristin/dalfopristin and linezolid. Although neither agent is a panacea, these recently released agents offer new options for therapy. (C) 2000 Lippincott Williams and Wilkins.
AB - Multidrug-resistant Gram-positive pathogens such as vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and methicillin-resistant coagulase-negative staphylococci account for a significant number of nosocomial infections, and new options for therapy have been lacking. During the past year, two agents have been released that have activity against these organisms: quinupristin/dalfopristin and linezolid. Although neither agent is a panacea, these recently released agents offer new options for therapy. (C) 2000 Lippincott Williams and Wilkins.
UR - http://www.scopus.com/inward/record.url?scp=0033673071&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033673071&partnerID=8YFLogxK
U2 - 10.1097/00001432-200012000-00003
DO - 10.1097/00001432-200012000-00003
M3 - Review article
C2 - 11964827
AN - SCOPUS:0033673071
SN - 0951-7375
VL - 13
SP - 593
EP - 598
JO - Current Opinion in Infectious Diseases
JF - Current Opinion in Infectious Diseases
IS - 6
ER -